This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Amber Balazs - Innovator in Cancer Treatment
Introduction
Amber Balazs is an emerging inventor based in Gaithersburg, MD (US). She is focused on developing innovative solutions for the treatment of cancer. Her work is particularly significant in the field of medicinal chemistry, where she explores new compounds that can potentially improve patient outcomes.
Latest Patent Applications
Amber Balazs has filed a patent application titled "SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER." This application discloses certain substituted pyrazine-2-carboxamides of Formula (I), along with their pharmaceutically acceptable salts. The compounds are designed to inhibit hematopoietic progenitor kinase 1 (HPK1), making them particularly useful in the treatment or prophylaxis of cancer.
Conclusion
Amber Balazs is making strides in the field of cancer treatment through her innovative research and patent applications. Her contributions may pave the way for new therapeutic options in oncology.